Juergen Reichardt

Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer

Ruty Mehrian‐Shai, C. D. Chen, Ting Shi et al. · Proceedings of the National Academy of Sciences · 2007 · 253 citations · Full text

Medicine, Molecular Biology, Oncology +17

A prevalent missense substitution that modulates activity of prostatic steroid 5alpha-reductase.

Nick Makridakis, Rachael K. Ross, Malcolm C. Pike et al. · PubMed · 1997 · 252 citations

Medicine, Genetics, Molecular Genetics +16

Biochemical and pharmacogenetic dissection of human steroid 5??-reductase type II

Nick Makridakis, E. Di Salle, Juergen Reichardt · Pharmacogenetics · 2000 · 211 citations

Life Sciences, Biochemistry, Pharmacology +17

Genetic variability of the human SRD5A2 gene: implications for prostate cancer risk.

Juergen Reichardt, Nick Makridakis, Brian E. Henderson et al. · PubMed · 1995 · 182 citations

Medicine, Genetics, Molecular Genetics +17

Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility.

Malcolm C. Pike, Gerhard A. Coetzee, Juergen Reichardt et al. · PubMed · 1998 · 160 citations

Medicine, Genetics, Oncology +16